A detailed history of Sharkey, Howes & Javer transactions in Abbott Laboratories stock. As of the latest transaction made, Sharkey, Howes & Javer holds 1,685 shares of ABT stock, worth $225,301. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,685
Holding current value
$225,301
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025

BUY
$111.1 - $140.22 $187,203 - $236,270
1,685 New
1,685 $223,000
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $18,432 - $20,391
158 Added 6.62%
2,543 $300,000
Q2 2020

Jul 22, 2020

BUY
$76.57 - $98.0 $182,619 - $233,730
2,385 New
2,385 $218,000
Q1 2020

Apr 24, 2020

SELL
$62.82 - $91.86 $149,825 - $219,086
-2,385 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $187,246 - $208,449
2,385 New
2,385 $207,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $234B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sharkey, Howes & Javer Portfolio

Follow Sharkey, Howes & Javer and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sharkey, Howes & Javer, based on Form 13F filings with the SEC.

News

Stay updated on Sharkey, Howes & Javer with notifications on news.